Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

AY Ali, L Farrand, JY Kim, S Byun… - Annals of the New …, 2012 - Wiley Online Library
Ovarian cancer is the most lethal gynecological malignancy. Cisplatin and its derivatives are
first‐line chemotherapeutics, and their resistance is a major hurdle in successful ovarian …

Targeting the PI3K pathway for cancer therapy

N Sadeghi, DE Gerber - Future medicinal chemistry, 2012 - Future Science
The PI3K pathway plays an important role in key cellular functions such as cell growth,
proliferation and survival. Genetic and epigenetic alterations in different pathway …

Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours

D Boller, KT Doepfner, A De Laurentiis… - Anticancer …, 2012 - ar.iiarjournals.org
Background: Eight human catalytic phosphoinositide 3-kinase (PI3K) isoforms exist which
are subdivided into three classes. While class I isoforms have been well-studied in cancer …

[HTML][HTML] Germline ablation of VGF increases lipolysis in white adipose tissue

S Fargali, T Scherer, AC Shin… - Journal of …, 2012 - joe.bioscientifica.com
Leptin, the peptide hormone product of the ob gene, regulates food intake and energy
expenditure at the hypothalamic level via the long-form of the leptin receptor (Ob-Rb). Leptin …

[PDF][PDF] PI3Kγ as a nodal point in μ-opioid receptor signaling

S Madishetti - 2012 - core.ac.uk
Phosphoinositide 3-kinases (PI3Ks) are a group of enzymes that catalyse the transfer of γ
phosphate group of ATP to the D3-position of inositol ring of phospotidylinositols (PtdIns) …

[PDF][PDF] Targeting class IA phosphoinositide 3-kinases in glioblastoma

K Höland - 2012 - zora.uzh.ch
Glioblastoma represents the most common and malignant cancer of the brain. After surgical
resection, the standard of care treatment for glioblastoma includes radiation therapy and …